Clay & AssociatesAdvocates
Clay & AssociatesAdvocates
  1. Home
  2. Industries
  3. Life sciences and healthcare

Life sciences and healthcare

Protecting research, ensuring compliance: regulatory licensing, pharmaceutical IP, health data protection and clinical research advisory.

Speak to counsel

Overview

Kenya's healthcare sector is undergoing transformation. UHC implementation, expanding private provision, pharmaceutical manufacturing growth, and increasing clinical research create opportunity and legal complexity.

We advise healthcare providers, pharma and biotech companies, medical device suppliers, and healthtech businesses on regulatory compliance, corporate structuring, IP, employment, data protection, and disputes.

Rated excellent on GoogleSee verified client reviews, updated live
Fees published before you callA public schedule, compliant with the Advocates (Remuneration) Order
Four mandates in one firmAdvocates, Notaries Public, Commissioners for Oaths and Patent Agents
Counsel across East AfricaNairobi-based, advising on cross-border matters throughout the region

What we do

12 service lines. Choose one to see what it covers.

Pharmaceutical and Medical Device Registration

We guide manufacturers, importers, and distributors through product and premises registration with the Pharmacy and Poisons Board under the Pharmacy and Poisons Act, Cap 244, covering medicines, medical devices, and in vitro diagnostics alike. This keeps a health product's two separate approval tracks moving together instead of stalling at the one an applicant forgot to plan for.

Most matters cross two or three of these

Describe the situation in your own words. We will tell you what it involves, which services it touches and what it will cost, before you commit to anything.

Describe your matter

Why clients instruct us for life sciences and healthcare work

The regulatory web, navigated whole

Pharmacy and Poisons Board, the Anti-Counterfeit Authority and health data obligations, which overlap rather than divide cleanly.

Pharmaceutical IP, including what Kenya lacks

We advise on patent strategy in a jurisdiction with no data exclusivity regime, where ordinary Industrial Property Act rules decide outcomes.

Clinical research and health data

Trial agreements and DPA 2019 compliance for sensitive personal data.

Device and product market entry

Registration work for manufacturers and distributors entering the Kenyan market.

Life sciences and healthcare insights

All life sciences and healthcare insights
Corporate & Commercial

Exit Strategies for Life Sciences Investors in Kenya: M&A, IPO and Trade Sale Compared

8 Sep 2026, 6 min read
Regulatory & Compliance

Cross-Border Licensing Deals: What Multinational Pharma Should Know About Kenyan Contract Law

8 Sep 2026, 6 min read
Corporate & Commercial

Listing on NSE GEMS: A Capital-Raising Option for Kenyan Health-Tech Companies

3 Sep 2026, 6 min read
Regulatory & Compliance

Manufacturing and Supply Agreements for Pharmaceutical Companies Operating in Kenya

3 Sep 2026, 6 min read
Regulatory & Compliance

From Trial to Market: Structuring Sponsor-Site Clinical Trial Agreements Under Kenyan Law

3 Sep 2026, 6 min read
Corporate & Commercial

IP Due Diligence in Life Sciences Deals: What Kenyan Investors and Acquirers Should Check

3 Sep 2026, 6 min read

Tell us about your product or practice

You will get a clear view of what the matter involves and what it costs before you commit to anything.

  • Your consultation fee is credited in full against your engagement fee if you instruct us within 14 days
  • Scope, approach and fee confirmed in writing before work begins
  • Our full fee schedule is published online
  • Nextgen Mall, 5th Floor, Suite 6, Mombasa Road, Nairobi